BlackRock Health Sciences Trust IIBMEZ
About: BlackRock Health Sciences Trust II is a closed-ended management investment company. The investment objective is to provide total return through a combination of current income and long-term capital appreciation. The Trust seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its total assets in equity securities of energy and natural resources companies and equity derivatives with exposure to the energy and natural resources industry.
Fund manager confidence
Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)
1% more capital invested
Capital invested by funds: $638M [Q4 2024] → $642M (+$4.24M) [Q1 2025]
0.05% less ownership
Funds ownership: 42.66% [Q4 2024] → 42.61% (-0.05%) [Q1 2025]
3% less repeat investments, than reductions
Existing positions increased: 33 | Existing positions reduced: 34
5% less funds holding
Funds holding: 102 [Q4 2024] → 97 (-5) [Q1 2025]
24% less first-time investments, than exits
New positions opened: 13 | Existing positions closed: 17
33% less funds holding in top 10
Funds holding in top 10: 3 [Q4 2024] → 2 (-1) [Q1 2025]
Research analyst outlook
We haven’t received any recent analyst ratings for BMEZ.
Financial journalist opinion









